Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer
Epithelial ovarian cancer is predominantly diagnosed at advanced stages which creates significant therapeutic challenges. As a result, the 5-year survival rate is low. Within ovarian cancer, significant tumor heterogeneity exists, and the tumor microenvironment is diverse. Tumor heterogeneity leads...
Guardado en:
Autores principales: | Madison Pereira, Kathy Matuszewska, Colin Jamieson, Jim Petrik |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ef36c2a4f82442c6839a11c27f7ad561 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Endocrine Disorders and Genital Infections Impair Gynecological Health in APECED (APS-1)
por: Viivi Saari, et al.
Publicado: (2021) -
Clinical Approach to Neuroendocrine Neoplasm Associated With Ovarian Teratoma
por: Marta Opalińska, et al.
Publicado: (2021) -
Premature ovarian failure could be an alarming sign of polyglandular autoimmune dysfunction
por: Saif Aasem, et al.
Publicado: (2017) -
Germline RET Leu56Met Variant Is Likely Not Causative of Multiple Endocrine Neoplasia Type 2
por: Anna Reimer Hansen, et al.
Publicado: (2021) -
Metabolomic Profiling of Poor Ovarian Response Identifies Potential Predictive Biomarkers
por: Haixia Song, et al.
Publicado: (2021)